Abstract
Development of novel triconjugates fusing melatonin/isatin/N-acylhydrazone targeting colorectal cancer: design, synthesis, biological, and in silico ADME/Tox profiling
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have